CC-90001

Cat. No.: 0225LY-1048

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: CC-90001 is an oral inhibitor of c-Jun N-terminal kinase that shows a preference for JNK1 over the JNK2 isoform.

Synonym: 1403859-14-2; CC90001; 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide; 2-((1,1-Dimethylethyl)amino)-4-(((1R,3R,4R)-3-hydroxy-4-methylcyclohexyl)amino)-5-pyrimidinecarboxamide; 5-Pyrimidinecarboxamide, 2-((1,1-dimethylethyl)amino)-4-(((1R,3R,4R)-3-hydroxy-4-methylcyclohexyl)amino)-; 2-(tert-butylamino)-4-(((1R,3R,4R)-3-hydroxy-4-methylcyclohexyl)amino)pyrimidine-5-carboxamide; 2-(tert-butylamino)-4-[[(1R,3R,4R)-3-hydroxy-4-methylcyclohexyl]amino]pyrimidine-5-carboxamide; 2-(tert-butylamino)-4-{[(1R,3R,4R)-3-hydroxy-4-methylcyclohexyl]amino}pyrimidine-5-carboxamide

CAS No.: 1403859-14-2

Compound CID: 71237511

Formula: C₁₆H₂₇N₅O₂

Formula Weight: 321.42

Specification

Relative Density: 1.224 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: CC-90001 can be used in fibrosis research to investigate the therapeutic potential of selective JNK inhibition in pulmonary and hepatic models.